

| 货号 | DW759018 |
|---|---|
| 品牌 | abinScience |
| 描述 |
Lirilumab ELISA Kit (DW759018) — Quantitative sandwich ELISA for Lirilumab. Sample: Plasma, Serum. Range: 0.31-5 μg/mL. Sensitivity: 0.156 μg/ml.
Highlights
|
| 样本类型 | Serum, plasma, and other biological fluid samples |
| 灵敏度 | 15.09 ng/mL |
| 检测范围 | 31.25 - 2,000 ng/mL |
| 种属反应性 | Human |
| 靶标 | CD158 antigen-like family member A,KIR2DL1,Killer cell immunoglobulin-like receptor 2DL1,Natural killer-associated transcript 1,NKAT-1,MHC class I NK cell receptor,CD158A,p58 natural killer cell receptor clones CL-42/47.11 |
| Accession号 | P43626,P43627,P43628 |
| 应用 | ELISA |
| 检测方法 | Colorimetric |
| 实验类型 | Competitive |
| 回收率 | 80-120% |
| 运输 | 2-8 ℃ |
| 稳定性和存储 | The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition. |
| 规格 | Lirilumab |
| 别名 | BMS-986015, IPH2102, 1000676-41-4 |
| 背景 | Lirilumab (IPH2102/BMS-986015/BMS-986015-01) is a fully human monoclonal antibody (mAb) that is designed to block the interaction between KIR2DL-1, -2, -3 inhibitory receptors and their ligands. This drug was developed by Innate Pharma and is licensed to Bristol-Myers Squibb. A phase 2 clinical trial for acute myeloid leukemia (AML) was terminated early ( |
| Note | For Research Use Only. |

Standard Curve of Lirilumab ELISA Kit



24小时产品查询

扫一扫关注我们

专属渠道经理